PLVJX
Price
$19.64
Change
+$0.11 (+0.56%)
Updated
Jul 3 closing price
Net Assets
3.55B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

PLVJX vs VVIAX

Header iconPLVJX vs VVIAX Comparison
Open Charts PLVJX vs VVIAXBanner chart's image
Principal Large Cap Value III J
Price$19.64
Change+$0.11 (+0.56%)
VolumeN/A
Net Assets3.55B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
PLVJX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PLVJX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLVJX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. PLVJX (3.55B). VVIAX pays higher dividends than PLVJX: VVIAX (2.18) vs PLVJX (1.13). PLVJX was incepted earlier than VVIAX: PLVJX (24 years) vs VVIAX (25 years). PLVJX (0.95) is less costly to investors than VVIAX (0.05). PLVJX is a more actively managed with annual turnover of: 41.10 vs. VVIAX (9.00). PLVJX has a lower initial minimum investment than VVIAX: PLVJX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. PLVJX (5.33). VVIAX return over 5 years is better than : 80.13 vs. PLVJX (45.59).
PLVJXVVIAXPLVJX / VVIAX
Total Expense Ratio0.930.051,860%
Annual Report Gross Expense Ratio0.950.051,900%
Fund Existence24 years25 years-
Gain YTD5.6486.19891%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets3.55B189B2%
Annual Yield % from dividends1.132.1852%
Returns for 1 year5.3312.0344%
Returns for 3 years16.6935.1747%
Returns for 5 years45.5980.1357%
Returns for 10 years40.57115.6735%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.